Policy & Regulation
Johnson & Johnson begins global Phase 3 registration trial for COVID-19 vaccine candidate
25 September 2020 - Johnson & Johnson (NYSE:JNJ) said on Thursday that its Janssen Pharmaceutical Companies pharmaceuticals division has launched a large-scale, international phase 3 registration ...
Rediscovery Life Sciences Completes USD 4.5m Series B Financing
24 September 2020 - - US-based biotechnology company Rediscovery Life Sciences, LLC, has closed aseries B financing co-led by REX Health Ventures (the investment arm of UNC REX Healthcare) and Orlando...
PointClickCare to Provide De-Identified Clinical Data to Industry-Wide COVID-19 Research Database
24 September 2020 - - Canada-based PointClickCare, a cloud-based software platform for the senior care market, will be joining the coalition of healthcare companies that have launched the COVID-1...
The Lancet Publishes Promising Data of Apeiron's APN01 (rhsACE2) to Treat COVID-19 in Named Patient Use
24 September 2020 - - The first, encouraging data with Austrian private biotechnology company Apeiron Biologics AG's clinical drug candidate APN01 (rhsACE2) to treat severe COVID-19 were publishe...
Congenica Launches New Host Genetics Module to Advance COVID-19 Research
24 September 2020 - - UK-based digital health company Congenica has launched a new module for its genomic analysis platform that will accelerate research into the relationship between an ind...
China's Sinovac planning on COVID-19 vaccine distribution in South America
24 September 2020 - The chairman of Sinovac Biotech (Sinovac)(NasdaqGS:SVA), a vaccine focused biopharmaceutical company in China, Yin Weidong, has said the company hopes to supply its experimental CO...
Related Headlines

Sinovac's Coronavac, SARS-CoV-2 Vaccine, Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children

Humanigen Inks Thermo Fisher Partnership to Expand Manufacturing for COVID-19 Therapeutic Candidate Lenzilumab

Parnell Pharmaceuticals develops Nomovid Antiviral Nasal Spray against Sars-CoV-2 and seeks FDA approval

Global Response Aid, FujiFilm Toyama Chemical and Dr Reddy's Laboratories discloses Avigan shows promising results in treatment of COVID patients in Japan

TrippBio to launch crowdfunding investment opportunity to develop COVID-19 treatment

Luminex secures USD683,500 from BARDA to support COVID-19 multiplex antibody test against future infection

NeuroRx files for FDA's EUA for RLF-100 in the treatment of patients with critical COVID-19

Vivet Therapeutics and Pfizer Enter into Manufacturing Agreement for Vivet's Investigational Gene Therapy for Wilson Disease

FDA Accepts Supplemental New Drug Application for Pfizer's Xalkori for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma

European Medicines Grants Priority Medicines Designation to bluebird bio's LentiGlobin for Sickle Cell Disease Gene Therapy

FDA Grants RMAT Designation to MultiStem Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome

Afimmune Initiates Epeleuton Phase IIb TRIAGE Study in Patients with High Triglycerides and Type 2 Diabetes

Johnson & Johnson initiates final study of single-shot COVID-19 vaccine in 60,000 volunteers

LabConnect names new director

Bridge Biotherapeutics confirms safety and efficacy profiles of BBT-401